Ligand Pharmaceuticals (LGND) Stock Chart & Stock Price History $160.10 +1.00 (+0.63%) As of 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ligand Pharmaceuticals Stock Price Performance The Ligand Pharmaceuticals (LGND) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 50.27%, with a year-to-date return of 49.42%. In the past month, the stock has increased 18.66%, reflecting recent market activity. As of the latest close, Ligand Pharmaceuticals traded at $159.10 with a market cap of $3.12 billion and volume of 140,463 shares. Five years ago, the stock traded at $103.25, representing a 55.06% increase over that period. At the time, it had a market cap of $1.74 billion and a volume of 124,186 shares. Receive LGND Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.64%1 Month Performance+18.66%3 Month Performance+59.80%Year-To-Date Performance+49.42%1 Year Performance+50.27%5 Year Performance+55.06% LGND Stock Chart for Thursday, August, 28, 2025 LGND Chart by TradingView Ligand Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/27/2025$159.76$159.10-0.41%$161.89$158.78140,463 shs$3.12 billion08/26/2025$158.79$159.76+0.61%$160.48$158.13102,134 shs$3.13 billion08/25/2025$159.08$158.79-0.18%$159.81$157.52119,645 shs$3.11 billion08/22/2025$157.31$159.08+1.13%$161.93$156.91234,074 shs$3.12 billion08/21/2025$155.25$157.31+1.33%$157.91$154.9195,396 shs$3.08 billion08/20/2025$154.07$155.25+0.77%$156.67$152.23153,878 shs$3.04 billion08/19/2025$153.26$154.07+0.53%$154.17$151.59113,224 shs$3.02 billion08/18/2025$151.08$153.26+1.44%$154.89$149.51204,053 shs$3.00 billion08/15/2025$153.79$151.08-1.76%$155.28$150.89245,447 shs$2.96 billion08/14/2025$156.01$153.79-1.42%$155.08$151.46203,333 shs$3.01 billion Get the Latest News and Ratings for LGND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/13/2025$152.69$156.01+2.17%$157.54$151.24352,303 shs$3.01 billion08/12/2025$147.01$152.69+3.86%$156.53$149.001.77 million shs$2.95 billion08/11/2025$150.06$147.01-2.03%$148.17$137.141.08 million shs$2.84 billion08/08/2025$146.32$150.06+2.56%$151.55$143.51195,533 shs$2.90 billion08/07/2025$142.40$146.32+2.75%$149.21$140.00300,219 shs$2.82 billion08/06/2025$135.15$142.40+5.36%$143.79$132.21300,453 shs$2.75 billion08/05/2025$135.39$135.15-0.18%$135.88$132.70185,753 shs$2.61 billion08/04/2025$132.72$135.39+2.01%$135.39$131.67103,535 shs$2.61 billion08/01/2025$131.58$132.72+0.87%$133.19$129.55155,992 shs$2.56 billion07/31/2025$135.23$131.58-2.70%$137.25$131.12227,706 shs$2.54 billion07/30/2025$131.58$135.23+2.77%$138.02$133.85181,685 shs$2.61 billion07/29/2025$134.92$131.58-2.48%$136.12$131.57100,938 shs$2.54 billion07/28/2025$135.83$134.92-0.67%$135.58$133.62118,763 shs$2.60 billion Related Companies ADMA Stock Chart ANIP Stock Chart BMRN Stock Chart EXEL Stock Chart MDGL Stock Chart EXAS Stock Chart HALO Stock Chart RGEN Stock Chart IONS Stock Chart ALKS Stock Chart Receive LGND Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LGND) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ligand Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Ligand Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access